Arkolith/Insider Trading/LIPO/Form 4

Kaufman Jonathan H

See remarks below., Director, 10% OwnerLIPELLA PHARMACEUTICALS INC. (LIPO) · full profile →Form 4 · filed Mar 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2025Other(J)85K—$0527K
Mar 10, 2025Other(J)29K—$029K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-25-000427) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML